IceCure Medical (ICCM) Retained Earnings (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Retained Earnings data on file, last reported at -$124.7 million in Q1 2026.

• Quarterly Retained Earnings changed N/A year-over-year to -$124.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$124.7 million (changed N/A YoY) and the FY2025 annual result came in at -$120.4 million, down 14.29% from the prior year.
• Retained Earnings slipped to -$124.7 million in Q1 2026 per ICCM's latest filing, from -$120.4 million in the prior quarter.
• Across five years, Retained Earnings topped out at -$75.4 million in Q4 2022 and bottomed at -$124.7 million in Q1 2026.
• The 5-year median for Retained Earnings is -$105.4 million (2024), against an average of -$103.2 million.
• The widest annual swing landed in 2022, when Retained Earnings fell 29.06%; it then fell 14.29% in 2025.
• Tracing ICCM's Retained Earnings over 5 years: stood at -$75.4 million in 2022, then dropped by 19.43% to -$90.1 million in 2023, then retreated by 17.01% to -$105.4 million in 2024, then slipped by 14.29% to -$120.4 million in 2025, then decreased by 3.55% to -$124.7 million in 2026.
• Per Business Quant, the three latest ICCM Retained Earnings figures stand at -$124.7 million (Q1 2026), -$120.4 million (Q4 2025), and -$105.4 million (Q4 2024).

Peer Comparison